Blade Therapeutics | Revolutionizing the Treatment of Fibrotic Disease

Discovering breakthroughs in fibrosis and neurodegeneration

Discovering breakthroughs in fibrosis and neurodegeneration

Discovering breakthroughs in fibrosis and neurodegeneration

Pipeline

We are positioned to build a pipeline across a range of fibrotic and neurodegenerative diseases.

Cudetaxestat
(Fibrosis)

Phase 2

BLD-2184
(Neurodegeneration)

IND Ready

Join our team

We are looking for people with the passion and commitment of the values we live by.

Passion and commitment to our mission

Accountability to the team

Integrity in everything we do

Be fearless

Recent News

May 18, 2022

Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference

May 16, 2022

Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference

May 13, 2022

Open letter to the respiratory community from Blade CEO Wendye Robbins, M.D.

Events

There are no events currently scheduled.

Bringing life changing and revolutionary treatments to patients with fibrotic and neurodegenerative diseases.